Reckitt Benckiser, a UK-based consumer goods company, recently paid $17.9 billion in cash for Mead Johnson, the paediatric nutrition supplier. Author Antoine Gara, writing for Forbes, argues that this is part of RB’s larger play to become the Procter & Gamble of the 21st century – and of emerging Asian markets. RB is “building a stable of household, personal care, and health brands that will benefit from rising consumer spending and population growth outside the United States,” Gara reports. And with investors increasingly interested, the author expects consumer-product conglomerates to continue fighting for mid-size acquisition targets.
Read more in Forbes >